Combitic Global Caplet Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Combitic Global Caplet Private Limited Pharmaceutical Export Portfolio Dataset — 19 Products, $46.1M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Combitic Global Caplet Private Limited — Pharmaceutical Exporter Profile (2026) | 19 Products, $46.1M Trade | TransData Nexus

Combitic Global Caplet Private Limited

Indian Pharmaceutical Exporter · Gastrointestinal Specialist · $46.1M Total Trade · DGFT Verified

Combitic Global Caplet Private Limited is an Indian pharmaceutical exporter with a total trade value of $46.1M across 19 products in 10 therapeutic categories. Based on 2,427 verified export shipments from Indian Customs (DGFT) records, Combitic Global Caplet Private Limited is the #1 Indian exporter in 4 products including Chlorpheniramine, Domperidone, Ranitidine. Top exports include Diclofenac ($10.8M), Omeprazole ($7.9M), Chlorpheniramine ($6.1M).

Combitic Global Caplet Private Limited — Export Portfolio & Destination Treemap

Combitic Global Caplet Private Limited pharmaceutical export portfolio — 19 products across 10 therapeutic categories. Source: Indian Customs (DGFT).

Who is Combitic Global Caplet Private Limited? — Company Overview & Market Position

Combitic Global Caplet Private Limited, established on December 30, 1981, is a privately held pharmaceutical company headquartered in New Delhi, India. The company operates under the Corporate Identification Number (CIN) U74999DL1981PTC012922 and is registered with the Registrar of Companies, Delhi. As of the latest available data, Combitic has an authorized capital of ₹5.00 crore and a paid-up capital of ₹4.02 crore.

The company specializes in the formulation and development of finished pharmaceutical products, including tablets, capsules, syrups, and injections. Combitic has a workforce of approximately 318 professionals dedicated to its operations. The registered office is located at 17, New Rohtak Road, Karol Bagh, New Delhi, Delhi, 110005.

What Does Combitic Global Caplet Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Diclofenac$10.8M 2Omeprazole

Product Portfolio — Top 19 by Export Value

Combitic Global Caplet Private Limited exports 19 pharmaceutical products across 10 therapeutic categories. Market leader (#1 exporter) in 4 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Diclofenac	Analgesics & Antipyretics	$10.8M	216	3.0%	2
2	Omeprazole	Gastrointestinal	$7.9M	205	1.2%	10
3	Chlorpheniramine	Antihistamines & Allergy	$6.1M	122	13.2%	1
4	Paracetamol	Analgesics & Antipyretics	$5.3M	308	1.5%	14
5	Domperidone	Gastrointestinal	$4.3M	276	14.7%	1
6	Phenylephrine	Respiratory & OTC	$3.7M	100	4.3%	4
7	Ranitidine	Gastrointestinal	$2.7M	68	21.4%	1
8	Lansoprazole	Gastrointestinal	$1.5M	152	0.5%	14
9	Levofloxacin	Antibiotics	$1.3M	27	1.8%	11
10	Rifampicin	Advanced Antibiotics	$803.7K	24	0.1%	10
11	Alprazolam	CNS & Psychiatric	$550.0K	11	3.3%	6
12	Levamisole	Antimalarial & Antiparasitic	$367.2K	25	13.8%	3
13	Herbal	Ayurvedic & Herbal Products	$333.1K	580	1.8%	11
14	Norfloxacin	Advanced Antibiotics	$174.3K	21	2.1%	11
15	Paracetamol Caffeine	Combination Drugs	$108.3K	12	7.8%	2
16	Taila	Ayurvedic & Herbal Products	$78.4K	147	1.0%	10
17	Kwatha	Ayurvedic & Herbal Products	$61.4K	105	11.5%	1
18	Gutika	Ayurvedic & Herbal Products	$6.3K	6	5.1%	4
19	Ghrita	Ayurvedic & Herbal Products	$4.2K	22	0.9%	5

Combitic Global Caplet Private Limited exports 19 pharmaceutical products across 10 therapeutic categories with a total export value of $46.1M. The company is the #1 Indian exporter in 4 products: Chlorpheniramine, Domperidone, Ranitidine, Kwatha. The top category is Gastrointestinal (35.6% of portfolio), followed by Analgesics & Antipyretics (34.9%), indicating a concentrated portfolio with the top 5 products accounting for 74.7% of total export value.

Combitic Global Caplet Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Combitic Global Caplet Private Limited operates manufacturing facilities in Sonepat, Haryana, India. The plant is equipped with modern machinery and adheres to stringent quality control measures to ensure the production of high-quality pharmaceutical products. Specific details regarding production capacities and specializations are not publicly disclosed.

3Key Leadership

The leadership team at Combitic Global Caplet Private Limited includes:

Dinesh Kaushik, Director, appointed on October 24, 2025.

Shashank Garg, Director, appointed on September 30, 2022.

Pavel Garg, Chairman, Director, and Founder.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Combitic Global Caplet Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Combitic Global Caplet Private Limited has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has obtained necessary regulatory approvals and market access in these regions, enabling it to export its pharmaceutical products. Specific details regarding regulatory filings, approvals, and market access status are not publicly disclosed.

2Emerging Markets

Combitic Global Caplet Private Limited has expanded its reach to emerging markets in Africa, Latin America, and Southeast Asia. The company has achieved WHO prequalification for certain products, facilitating access to these regions. Specific details regarding market penetration and product approvals are not publicly disclosed.

3Geographic Strategy

Combitic Global Caplet Private Limited demonstrates a diversified geographic strategy by exporting its pharmaceutical products to various regions, including regulated markets and emerging economies. This approach mitigates concentration risk and aligns with the company's strategic direction to expand its global footprint.

Combitic Global Caplet Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Combitic Global Caplet Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly disclosed.

2WHO & EU GMP

Combitic Global Caplet Private Limited has achieved WHO prequalification for certain products, indicating compliance with international quality standards. Specific details regarding EU Good Manufacturing Practice (GMP) certificates and European Directorate for the Quality of Medicines & HealthCare (EDQM) status are not publicly disclosed.

3CDSCO & Indian Regulatory

Combitic Global Caplet Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO) and has obtained necessary approvals from state drug controllers. The company has also secured export No Objection Certificates (NOCs) for its pharmaceutical products. Specific details regarding these regulatory approvals are not publicly disclosed.

Combitic Global Caplet Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Combitic Global Caplet Private Limited operates in a competitive pharmaceutical market, with several companies offering similar products across various therapeutic categories. While specific market share comparisons and head-to-head analyses are not publicly available, the company's diverse product portfolio and global export reach position it as a significant player in the industry.

2Key Differentiators

Combitic Global Caplet Private Limited's key differentiators include its extensive experience in pharmaceutical formulation and development, a diverse product portfolio across multiple therapeutic categories, and a strong presence in both regulated and emerging markets. These factors contribute to the company's competitive advantage in the global pharmaceutical industry.

3Strategic Position

Combitic Global Caplet Private Limited's current strategic direction focuses on the export of finished pharmaceutical formulations, encompassing tablets, capsules, syrups, and injections. The company's future outlook includes expanding its global footprint, enhancing product offerings, and strengthening its position in both regulated and emerging markets.

Buyer Due Diligence Brief — Evaluating Combitic Global Caplet Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Combitic Global Caplet Private Limited has a track record of consistent export volume, with a total export value of $46.1 million USD and 2,427 shipments across 19 products in 10 therapeutic categories from 2022 to 2026. The company's reliability is indicated by its market leadership in products such as Chlorpheniramine and Domperidone, where it holds a 13.2% and 14.7% market share, respectively.

2Certifications to Verify

Importers should verify the following certifications when considering Combitic Global Caplet Private Limited as a supplier:

FDA Facility Registration: Confirm the company's registration status with the U.S. Food and Drug Administration.

WHO-GMP Certification: Ensure compliance with World Health Organization Good Manufacturing Practice standards.

EU GMP Certification: Verify adherence to European Union Good Manufacturing Practice guidelines.

Frequently Asked Questions — Combitic Global Caplet Private Limited

How many pharmaceutical products does Combitic Global Caplet Private Limited export from India?

Combitic Global Caplet Private Limited exports 19 pharmaceutical products across 10 therapeutic categories. The top exports are Diclofenac ($10.8M), Omeprazole ($7.9M), Chlorpheniramine ($6.1M), Paracetamol ($5.3M), Domperidone ($4.3M). Total export value is $46.1M.

What is Combitic Global Caplet Private Limited's total pharmaceutical export value?

Combitic Global Caplet Private Limited's total pharmaceutical export value is $46.1M, based on 2,427 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Combitic Global Caplet Private Limited the #1 Indian exporter?

Combitic Global Caplet Private Limited is the #1 Indian exporter in 4 products: Chlorpheniramine (13.2% market share), Domperidone (14.7% market share), Ranitidine (21.4% market share), Kwatha (11.5% market share).

What therapeutic categories does Combitic Global Caplet Private Limited cover?

Combitic Global Caplet Private Limited exports across 10 therapeutic categories. The largest are Gastrointestinal (35.6%, 4 products), Analgesics & Antipyretics (34.9%, 2 products), Antihistamines & Allergy (13.2%, 1 products).

Get Full Combitic Global Caplet Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.